The heart that just survived is left unable to help itself.
Each year, roughly 350,000 Americans collapse outside a hospital with their hearts in arrest. Only about 35,000 of them make it out alive. For the rest, and even for many who are resuscitated, the damage done in those minutes without blood flow proves fatal in the hours and days that follow. A researcher at Case Western Reserve University thinks he may have found out why — and the American Heart Association has decided the answer is urgent enough to fund immediately.
Cody Rutledge, an assistant professor of medicine at Case Western's School of Medicine, has identified something that had not been recognized before: after cardiac arrest, the heart's own internal repair machinery goes quiet. It doesn't just slow down. It stops.
The specific culprit Rutledge identified is the mitochondrial ribosome — a molecular structure inside heart cells whose job is to manufacture the proteins those cells need to produce energy. When the heart is starved of blood flow and then has that flow restored, this ribosome ceases to function. Without it, the heart cannot build what it needs to recover. The organ that just survived a catastrophic event is left, at the cellular level, unable to help itself.
The American Heart Association has responded by awarding Case Western its Rapid Impact Research Award — a designation the organization reserves for work it considers high-priority and capable of reaching patients quickly. The grant is designed to accelerate research that might otherwise take years to move through the usual funding cycles.
With that support, Rutledge's team will now pursue two lines of inquiry. The first is confirmatory: they want to establish definitively that the shutdown of mitochondrial protein production is a root cause of the heart dysfunction that kills survivors in the aftermath of resuscitation, not merely a byproduct of it. The second is therapeutic: they will test whether delivering specific nutrients and compounds to heart cells can restart that protein production and, in doing so, improve the odds of survival.
Rutledge has noted that the implications of his findings reach well beyond cardiac arrest. The biological process his team is studying — the damage that occurs when blood flow is cut off from an organ and then suddenly restored — is the same process at work in heart attacks and in strokes that occur during major surgery. It is a phenomenon with a clinical name, ischemia-reperfusion injury, and it sits at the center of some of the most lethal and least-solved problems in medicine. Any treatment that emerges from this research could, in theory, benefit a far larger population than the tens of thousands who survive cardiac arrest each year.
The scale of the problem makes the stakes plain. Of the 350,000 Americans who go into cardiac arrest outside a hospital annually, nine in ten do not survive. Those who do are not out of danger — the period immediately following resuscitation carries its own serious risk of death, driven in large part by the very cellular dysfunction Rutledge is now positioned to study in depth.
What comes next is the hard work of confirmation and experimentation. If the team can show that mitochondrial protein production is not just a marker of cardiac damage but a driver of it, and if they can identify compounds that reliably restart that process, the path toward a clinical intervention becomes considerably shorter. The AHA's Rapid Impact designation exists precisely to compress that timeline. The research is early, but the question it is asking — why does the heart fail to save itself — is one that medicine has not yet answered.
Notable Quotes
Our findings extend well beyond cardiac arrest — the mechanisms we're investigating are central to heart attack, stroke, and major surgical complications.— Cody Rutledge, assistant professor of medicine, Case Western Reserve University School of Medicine
The Hearth Conversation Another angle on the story
What's the thing that most people get wrong when they think about surviving cardiac arrest?
They think survival means the crisis is over. But for many patients, the most dangerous window comes after the heart restarts.
Why is that?
Because restoring blood flow doesn't automatically restore function. The cells that were starved of oxygen can't just pick up where they left off.
And that's what Rutledge found — that the repair system itself shuts down?
Exactly. The mitochondrial ribosome, which builds the proteins heart cells need to generate energy, stops working. The heart is running on empty at the moment it needs the most.
Is this something that was suspected before, or did he find it from scratch?
It had gone unrecognized. That's what makes it significant — not just a new detail, but a missing piece that changes how we understand why survivors deteriorate.
What would a treatment actually look like if this research pans out?
Potentially something delivered in the hours after resuscitation — specific nutrients or compounds that prompt the mitochondrial ribosome to start working again. Simple in concept, very hard to get right.
And the AHA's Rapid Impact award — what does that actually mean in practice?
It means the association looked at this and said it's too important to wait in a normal funding queue. It's a signal that the science is credible and the need is acute.
You mentioned the findings extend beyond cardiac arrest. How far does that reach?
Ischemia-reperfusion injury — blood cut off, then restored — is central to heart attacks and surgical strokes too. If you solve the mechanism in one context, you may have a key that fits several locks.